SOURCE: iSatori

iSatori

May 30, 2013 10:00 ET

iSatori, Inc. to Present at Sidoti & Company Micro-Cap Conference on Friday, June 7, 2013

GOLDEN, CO--(Marketwired - May 30, 2013) - iSatori, Inc. (OTCQB: IFIT) ("the Company"), an emerging leader in the development and marketing of scientifically engineered nutritional supplements for healthier lifestyles, today announced it will be presenting at the Sidoti & Company Semi-Annual Micro-Cap Conference on Friday, June 7, 2013. The conference will be held at the Grand Hyatt New York Hotel in New York City.

The Company's Chief Executive Officer, Stephen Adele, is scheduled to present at 11:20 a.m. Eastern Time in the Edison Room (Estate 2).

Management of iSatori, Inc. will be available for one-on-one meetings with investors during the day at the conference. Investors interested in arranging one-on-one meetings should contact their Sidoti representative.

About Sidoti & Company, LLC

Sidoti & Company, LLC, founded in 1999, continues to set the Wall Street standard for independent small-cap equity research, while rapidly becoming a driving force in micro-cap research, launching coverage of more than 400 equities of $250 market cap or less since mid-2010. Its analysts mine dozens of industries to provide unbiased, institutional-quality research focusing on the investment merits of profitable companies at a sub-$3 billion market cap, and its goal was to extend coverage to 500 micro-cap equities by the end of 2012.

About iSatori, Inc.

iSatori is a consumer products firm that develops and sells nutritional products through online marketing, Fortune 500 retailers, and thousands of retail stores around the world. The Company is headquartered in Golden, Colorado, and its common stock trades on the OTCQB market under the symbol "IFIT." More information about the Company is available at http://www.isatori.com.

Contact Information

  • For additional information, please contact:

    Stephen Adele
    (303) 215-9174
    Email Contact

    or

    RJ Falkner & Company, Inc.
    Investor Relations Counsel
    (830) 693-4400
    Email Contact